human
chymas
import
target
treatment
cardiovascular
diseas
use
seri
theoret
method
like
pharmacophor
model
databas
screen
molecular
dock
densiti
function
theori
dft
calcul
investig
identif
novel
chymas
inhibitor
specifi
key
factor
crucial
bind
interact
chymas
inhibitor
perform
highli
correl
r
pharmacophor
model
two
hydrogen
bond
acceptor
three
hydrophob
aromat
featur
gener
success
valid
appli
databas
screen
hit
compound
subject
variou
druglik
filtrat
molecular
dock
studi
final
three
structur
divers
compound
high
gold
fit
score
interact
key
activ
site
amino
acid
identifi
potent
chymas
hit
moreov
dft
studi
open
access
int
j
mol
sci
perform
confirm
clear
trend
electron
properti
inhibitori
activ
ic
data
thu
success
valid
dft
method
therefor
research
exert
help
develop
new
potent
hit
chymas
addit
combin
use
dock
orbit
energi
molecular
electrostat
potenti
analysi
also
demonstr
good
endeavor
gain
insight
interact
chymas
inhibitor
rais
blood
pressur
especi
systol
pressur
hypertens
one
strike
factor
induc
variou
diseas
like
heart
failur
stroke
myocardi
infarct
arteri
aneurysm
lead
caus
chronic
kidney
failur
treatment
hypertens
decreas
circul
volum
andor
slack
blood
vessel
angiotensin
ii
import
role
regul
blood
pressur
also
develop
vascular
wall
remodel
convers
angiotensin
ang
angiotensin
ii
ang
ii
catalyz
wellknown
angiotensinconvert
enzym
ace
metalloproteinas
dipeptidylcarboxypeptidas
activ
howev
chymas
ec
chymotrypsinlik
enzym
express
secretori
granul
mast
cell
also
catalyz
product
angiotensin
ii
vascular
tissu
even
ace
block
figur
chymasedepend
convers
angiotensin
angiotensin
ii
precursor
activ
form
chymas
convert
ang
ang
ii
greater
effici
select
ace
rate
convers
chymas
approxim
four
fold
higher
ace
chymas
show
enzymat
activ
immedi
releas
interstiti
tissu
ph
follow
variou
stimuli
tissu
sinc
chymas
enzymat
activ
normal
tissu
chymas
inhibitor
expect
high
safeti
chymas
inhibitor
may
effect
target
normal
tissu
order
gener
ang
ii
human
monkey
dog
hamster
chymas
cleav
angiotensin
peptid
bond
chymas
also
convert
precursor
transform
growth
matrix
metalloproteinas
mmp
activ
form
thu
contribut
vascular
respons
injuri
involv
tissu
inflamm
fibrosi
result
organ
damag
previou
studi
demonstr
involv
chymas
escal
dermat
chronic
inflamm
pursu
cardiac
pulmonari
fibrosi
therefor
inhibit
chymas
like
divulg
therapeut
way
treatment
cardiovascular
diseas
allerg
inflamm
fibrot
disord
chymas
inhibit
may
also
use
prevent
progress
type
diabet
along
prevent
diabet
retinopathi
moreov
role
chymas
inflamm
prompt
restor
valu
diseas
chronic
obstruct
pulmonari
diseas
copd
asthma
chymas
inhibitor
imper
elucid
physiolog
function
chymas
potenti
use
therapeut
agent
sever
chymas
inhibitor
sulfonyl
fluorid
deriv
bocvalpropheco
zileglupropheco
f
phecogluaspargom
n
carboxamido
deriv
n
n
amino
nonanoyl
lphenylalanin
ethyl
ester
deriv
deriv
methyllinderon
deriv
chloromethyl
keton
deriv
deriv
phenylsulfonyl
deriv
report
previous
gener
chymas
inhibitor
readili
decompos
plasma
thu
stabil
chymas
inhibitor
human
plasma
alway
matter
great
concern
drug
candid
essenti
enhanc
stabil
activ
compound
human
plasma
alway
dire
need
search
stabl
inhibitor
high
activ
human
chymas
mani
studi
indic
comput
approach
predict
drugtarget
interact
network
predict
bodi
fluid
predict
hiv
cleavag
site
protein
predict
protein
metabol
stabil
predict
signal
peptid
identif
dna
bind
protein
predict
network
substrateenzymeproduct
triad
predict
protein
subcellular
locat
predict
proteas
type
predict
antimicrobi
peptid
predict
membran
protein
type
predict
gpcr
type
identifi
nuclear
receptor
subfamili
predict
gramneg
bacteri
protein
cellular
locat
predict
transcript
activ
multipl
site
mutant
provid
mani
use
insight
data
would
timeconsum
costli
obtain
experi
alon
actual
data
combin
inform
deriv
structur
bioinformat
tool
see
eg
time
provid
use
insight
basic
research
drug
develop
view
present
studi
attempt
develop
new
comput
model
method
hope
may
becom
use
tool
drug
develop
quantit
structureact
relationship
qsar
studi
help
approach
quantit
understand
relationship
molecular
structur
inhibitor
biolog
activ
pharmacophor
model
studi
success
appli
previous
variou
drug
discoveri
research
includ
glycoprotein
gp
iibiiia
antagonist
h
antihistamin
dihydrofol
reductas
inhibitor
electron
molecular
featur
electron
densiti
frontier
molecular
orbit
densiti
field
lowest
unoccupi
molecular
orbit
lumo
highest
occupi
molecular
orbit
homo
molecular
electrostat
map
also
reveal
signific
qsar
studi
explain
biolog
activ
molecular
properti
homo
densiti
field
use
studi
ace
inhibitor
lumo
densiti
field
found
import
explain
mutagen
thu
determin
molecular
electron
properti
respons
potent
activ
select
chymas
inhibitor
illumin
fundament
molecular
level
forc
respons
potenc
variou
qsar
studi
chymas
inhibitor
also
perform
qsar
analysi
anhydridetyp
chymas
inhibitor
show
aromat
substitu
play
import
role
determin
inhibitori
potenc
compound
hayashi
cowork
show
introduct
variou
substitu
chloromethyl
keton
deriv
result
variat
activ
human
chymas
qsar
model
identif
stabl
chymas
inhibitor
also
develop
yuuki
et
al
subject
present
studi
develop
qsar
model
explor
key
molecular
featur
chymas
inhibitor
influenc
proteinligand
bind
interact
explor
depend
inhibitori
activ
upon
variou
physiochem
properti
compound
order
accomplish
task
exclus
comput
strategi
appli
use
variou
qsar
model
build
techniqu
pharmacophor
model
molecular
dock
densiti
function
theori
dft
figur
first
phase
calcul
pharmacophor
model
compris
key
chemic
featur
identif
novel
divers
chymas
inhibitor
gener
valid
pharmacophor
model
use
structur
search
queri
find
new
class
compound
similar
chemic
featur
chemic
databas
obtain
hit
scrutin
base
estim
activ
calcul
druglik
properti
molecular
dock
also
perform
evalu
compound
import
bind
site
interact
affin
final
carri
dftbase
qsar
studi
set
chymas
inhibitor
retain
structur
divers
wide
biolog
activ
rang
along
potent
hit
retriev
newli
develop
pharmacophor
model
object
dft
studi
twofold
one
purpos
deriv
qsar
model
scrutin
use
conceptu
dft
quantiti
moreov
also
serv
valid
techniqu
gener
pharmacophor
model
variou
electron
properti
lumo
homo
locat
molecular
electrostat
potenti
comput
result
studi
expect
explor
crucial
molecular
featur
contribut
bind
specif
use
understand
molecular
mechan
compound
act
util
get
compound
better
activ
ration
modif
one
main
object
present
studi
gener
pharmacophor
model
identif
novel
chymas
inhibitor
accomplish
ten
hypothes
imper
statist
paramet
gener
hypogen
modul
ds
use
train
set
compound
figur
hypothes
gener
cost
function
correl
valu
estim
fix
cost
total
cost
null
cost
valu
calcul
hypogen
modul
hypothes
gener
fix
cost
lowest
possibl
cost
repres
hypothet
simplest
model
fit
data
perfectli
wherea
null
cost
valu
equal
maximum
occur
error
cost
statist
signific
hypothesi
greater
differ
two
cost
valu
possibl
correl
experiment
estim
activ
data
enhanc
cost
differ
bit
total
null
cost
valu
present
work
null
cost
valu
top
hypothes
fix
cost
valu
thu
differ
bit
fix
cost
null
cost
consign
meaning
pharmacophor
model
moreov
total
cost
gener
hypothesi
closer
fix
cost
ten
gener
hypothes
score
total
cost
closer
fix
cost
lead
good
model
statist
signific
factor
includ
cost
valu
correl
coeffici
r
pharmacophor
featur
root
mean
squar
deviat
rmsd
hypothes
list
tabl
configur
cost
enumer
entropi
hypothet
space
valu
exceed
maximum
valu
signific
pharmacophor
model
configur
cost
valu
obtain
pharmacophor
gener
calcul
seven
hypothes
made
five
pharmacophor
featur
anoth
three
shown
four
featur
hyar
common
featur
among
hypothes
nine
hypothes
hydrogenbond
acceptor
hba
three
hypothes
ring
aromat
ra
one
hypothesi
made
hydrogen
bond
donor
hbd
consist
two
hba
three
hyar
featur
score
better
correl
cost
differ
valu
rmsd
valu
indic
qualiti
predict
train
set
rmsd
ten
hypothes
rang
show
lowest
rmsd
valu
correl
coeffici
repres
good
correl
linear
regress
geometr
fit
index
result
constru
best
rank
pharmacophor
model
among
hypothes
figur
basi
activ
compound
belong
train
test
set
categor
activ
scale
activ
ic
inhibitori
concentr
nm
moder
activ
ic
nm
less
activ
ic
nm
inact
ic
nm
activ
compound
estim
base
best
rank
pharmacophor
model
experiment
estim
activ
valu
train
set
compound
base
list
tabl
analysi
activ
predict
train
set
compound
reveal
activ
compound
predict
scale
wherea
one
moder
activ
compound
estim
less
activ
three
inact
compound
estim
less
activ
compound
among
compound
train
set
estim
activ
valu
least
activ
compound
train
set
base
nm
respect
close
experiment
activ
valu
nm
result
reveal
structur
characterist
explain
differ
biolog
activ
present
figur
activ
compound
could
map
featur
best
pharmacophor
model
fit
valu
carbonyl
oxygen
atom
attach
piperazin
ring
azetidinon
moieti
map
onto
two
hba
featur
three
phenyl
ring
present
activ
compound
map
three
hyar
featur
least
activ
compound
train
set
map
fit
valu
miss
two
hyar
featur
compar
compound
carbonyl
group
imidazolidinedion
carboxyl
group
least
activ
compound
map
hba
featur
wherea
phenyl
ring
attach
imidazolidinedion
map
one
hyar
featur
figur
valid
suggest
pharmacohor
model
perform
two
differ
valid
method
name
test
set
predict
fischer
random
method
test
set
contain
compound
repres
divers
activ
class
differ
function
group
use
valid
process
test
compound
import
ds
divers
conform
built
manner
train
set
compound
estim
activ
test
set
compound
calcul
base
geometr
fit
compound
analys
estim
activ
test
set
compound
demonstr
remark
result
test
set
compound
compound
show
error
valu
less
hardli
differ
experiment
estim
activ
valu
tabl
eight
nine
activ
compound
estim
activ
scale
wherea
ninth
compound
predict
moder
activ
seventeen
moder
activ
compound
estim
scale
wherea
remain
nine
estim
less
activ
compound
less
activ
compound
estim
less
activ
scale
furthermor
three
inact
compound
predict
less
activ
compound
thu
abil
forecast
activ
test
set
compound
impress
outstand
correl
valu
achiev
experiment
estim
activ
test
set
compound
correl
plot
show
correl
experiment
estim
activ
valu
train
test
set
compound
gener
display
figur
anoth
valid
method
base
fischer
random
also
perform
train
set
compound
verifi
qualiti
valid
process
confid
level
select
thu
spreadsheet
tabl
gener
data
obtain
valid
method
produc
better
statist
valu
compar
run
three
correl
valu
compar
less
correl
valu
total
cost
valu
random
model
rmsd
valu
higher
appropri
good
pharmacophor
model
therefor
valid
test
also
endow
high
level
assur
suggest
pharmacophor
model
develop
far
divulg
fairli
accur
idea
requir
molecular
featur
new
lead
therefor
appli
search
queri
retriev
molecul
novel
desir
attribut
chemic
databas
maybridg
chembridg
total
hit
compound
compound
maybridg
compound
chembridg
respect
obtain
molecular
properti
calcul
hit
compound
retriev
databas
hit
compound
maybridg
chembridg
databas
respect
estim
activ
valu
closer
activ
compound
train
set
select
evalu
hit
filter
use
lipinsiki
rule
five
evalu
druglik
determin
chemic
compound
certain
pharmacolog
biolog
activ
properti
would
make
feasibl
oral
activ
drug
human
compound
chembridg
databas
compound
maybridg
databas
satisfi
requir
lipinsiki
rule
five
druglik
compound
thu
hit
compound
satisfi
lipinsiki
rule
five
total
hit
subject
molecular
dock
train
set
compound
along
databas
hit
retriev
databas
screen
process
dock
protein
activ
site
use
gold
genet
optim
ligand
dock
dock
program
gold
fit
score
differenti
molecul
account
interact
pattern
calcul
molecul
activ
compound
train
set
compound
score
dock
score
exhibit
variou
hydrogenbond
interact
key
activ
site
residu
figur
moreov
two
carbonyl
oxygen
atom
near
middl
ring
map
hba
featur
show
hydrogenbond
interact
residu
activ
site
previou
studi
chymas
also
divulg
import
key
amino
acid
activ
site
region
enzym
along
divers
hydrogenbond
contact
phenyl
group
compound
map
hyar
featur
show
interact
aromat
ring
residu
moreov
compound
also
show
hydrophob
interact
amino
acid
sever
hit
compound
obtain
databas
screen
process
also
show
high
gold
fit
score
form
interact
activ
site
residu
hit
compound
show
fit
score
select
final
hit
evalu
process
intriguingli
final
three
compound
obtain
maybridg
databas
none
chembridg
databas
compound
show
estim
activ
valu
nm
score
gold
fit
score
also
exhibit
key
interact
import
amino
acid
like
activ
site
enzym
figur
phenyl
part
anisol
ring
pyridin
ring
map
hyar
featur
instig
improv
bind
compound
better
hydrophob
interact
compound
also
retriev
maybridg
databas
estim
activ
valu
nm
shown
gold
fit
score
compound
form
variou
close
contact
lead
import
ligandenzym
interact
hydrogen
bond
interact
hydrophob
interact
amino
acid
activ
site
enzym
figur
moreov
import
interact
fuse
ring
system
side
chain
imidazol
ring
amino
acid
also
reveal
furthermor
also
show
hydrophob
interact
amino
acid
residu
protein
hydrophob
group
map
hyar
featur
third
hit
estim
activ
valu
nm
gold
fit
score
form
hydrogen
bond
network
activ
site
residu
figur
benzen
ring
oxygen
atom
benzenesulfon
acid
moieti
hit
compound
overlaid
hyar
hba
featur
respect
enabl
consider
hydrophob
polar
interact
import
amino
acid
activ
site
map
top
three
databas
final
hit
molecular
structur
depict
figur
respect
three
hit
compound
map
entir
featur
best
pharmacophor
model
thu
design
potent
inhibitor
chymas
compound
show
import
result
respect
properti
estim
activ
calcul
druglik
properti
better
gold
fit
score
propos
potenti
lead
novelti
search
use
scifind
scholar
pubchem
compound
search
also
ascertain
hit
report
earlier
chymas
inhibit
electrostat
featur
impact
inhibitori
effect
chymas
inhibitor
investig
aim
provid
use
inform
understand
structur
inhibit
relationship
chymas
inhibitor
structur
least
activ
compound
train
set
optim
along
three
final
databas
hit
compound
level
statist
signific
factor
homo
lumo
mesp
compound
calcul
accord
fukui
frontier
orbit
approxim
frontier
orbit
homo
lumo
chemic
speci
import
defin
reactiv
fukui
first
recogn
import
frontier
orbit
princip
factor
govern
eas
chemic
reaction
stereoselect
path
parr
yang
demonstr
frontier
theori
ration
dft
whole
dataset
molecul
taken
account
appar
trend
inhibitori
activ
ic
data
increas
homo
energi
observ
figur
compound
homo
energi
rang
ev
high
valu
e
homo
like
indic
tendenc
molecul
donat
electron
appropri
acceptor
molecul
low
empti
molecular
orbit
energi
correl
homo
energi
ic
data
indic
homo
inhibitor
may
transfer
electron
less
energi
lumo
amino
residu
activ
site
chymas
calcul
show
compound
shown
highest
ev
lowest
ev
homo
level
energi
respect
trend
good
agreement
experiment
observ
suggest
compound
exhibit
highest
nm
lowest
nm
inhibitori
profil
respect
investig
chymas
inhibitor
btb
shown
highest
ev
homo
level
energi
among
hit
compound
even
higher
homo
energi
level
compound
two
hit
compound
also
show
higher
e
homo
least
activ
compound
data
set
previou
studi
high
homo
energi
level
also
play
import
part
activ
activ
dual
select
lox
inhibitor
moreov
clear
trend
inhibitori
activ
ic
data
lumo
energi
compound
also
reveal
compound
lumo
energi
rang
ev
compound
btb
show
highest
lumo
level
energi
least
activ
compound
demonstr
lumo
lowest
energi
homo
lumo
site
plot
onto
molecular
surfac
activ
least
activ
compound
data
set
along
two
hit
btb
ht
compound
figur
often
heteroaromat
ring
contain
heteroatom
nitrogen
oxygen
region
compound
act
electron
donor
acceptor
activ
site
chymas
experiment
studi
also
deduc
introduct
heteroatom
inhibitor
compound
enhanc
stabil
human
plasma
instanc
placement
ethoxi
group
compound
instig
stabil
electron
donor
ring
identifi
greatest
electron
densiti
homo
case
compound
homo
scatter
moieti
togeth
carbonyl
group
lumo
spread
region
contain
heteroatom
like
oxygen
nitrogen
dock
result
also
show
region
compound
involv
import
interact
key
residu
protein
compound
homo
compos
anilin
ring
lumo
spread
sulfonyl
benzoic
acid
group
lumo
plot
methylbenzenesulfonamid
group
hit
compound
btb
show
hydrogen
bond
interact
import
amino
acid
activ
site
enzym
wherea
homo
plot
scatter
group
dihydroquinazolin
moieti
six
member
ring
part
dihydroquinazolin
group
involv
import
interact
side
chain
imidazol
ring
amino
acid
ht
hit
compound
homo
lumo
compos
methoxybenzen
benzoindazol
moieti
oxadiazol
substitut
pyridin
moieti
respect
overlay
ht
dock
protein
also
specul
involv
group
key
interact
activ
site
protein
effect
orbit
energi
inhibit
activ
associ
charg
transfer
stack
inhibitor
aromat
amino
acid
residu
bind
site
chymas
result
molecular
dock
studi
chymas
inhibitor
also
prove
presenc
kind
interact
electrostat
potenti
wide
use
character
molecul
especi
biomolecul
take
special
effect
biomolecular
recognit
predict
function
site
nam
et
al
report
discoveri
electrostat
interact
account
major
rate
acceler
mechan
rna
transphosphoryl
solut
catalyz
hairpin
ribozym
daga
doerksen
state
bind
mode
role
stereoelectron
properti
bind
spiroquinazolinon
show
phosphodiesteras
inhibitori
activ
recent
electrostat
funnel
illumin
threedimension
map
electrostat
potenti
report
dehez
et
al
drive
diphosph
nucleotid
rapidli
toward
bottom
intern
caviti
membraneprotein
mitochondri
adpatp
carrier
form
privileg
passageway
consid
discoveri
comprehens
suppos
electrostat
potenti
inhibitor
also
play
signific
role
bind
interact
chymas
togeth
orbit
energi
consequ
influenc
inhibit
effect
isosurfac
map
mesp
interpol
electron
densiti
surfac
constant
electron
charg
densiti
eau
well
known
electrostat
potenti
defin
interact
energi
posit
remot
charg
point
nuclei
electron
molecul
plot
electron
densiti
ed
mesp
compound
btb
ht
shown
figur
red
blue
color
repres
electroneg
electroposit
potenti
wherea
green
repres
potenti
halfway
two
extrem
color
area
surfac
repres
overal
molecular
charg
distribut
electrostat
potenti
compound
studi
electroneg
potenti
mesp
min
code
red
mesp
map
rang
kcalmol
indic
strongest
attract
interpol
blue
map
repres
electroposit
potenti
mesp
max
strongest
repuls
vari
kcalmol
predomin
green
region
mesp
surfac
correspond
potenti
halfway
two
extrem
indic
red
blue
color
respect
mesp
plot
onto
constant
electron
densiti
surfac
activ
compound
show
electroneg
potenti
region
red
color
oxygen
atom
carbonyl
group
near
piperazin
moieti
howev
case
least
activ
compound
neg
potenti
due
sulfonyl
carbonyl
oxygen
atom
miss
hit
compound
appear
local
neg
potenti
region
locat
oxygen
atom
carbonyl
sulfonyl
group
nitrogen
pyridin
ring
consist
dock
result
recogn
region
hydrogen
bond
acceptor
moreov
one
promin
local
neg
charg
region
protrud
oxadiazol
group
orient
adjac
recogn
hydrogen
bond
acceptor
strong
electrostat
interact
neg
potenti
key
residu
name
format
hydrogen
bond
enhanc
inhibit
effect
substanti
togeth
orbit
interact
exchang
energi
blue
electroposit
map
compound
mainli
distribut
methyl
group
hydrogen
atom
attach
sixmemb
ring
also
bear
maximum
brunt
posit
charg
blue
region
due
accumul
posit
potenti
moieti
exhibit
interact
aromat
residu
activ
site
molecular
electrostat
potenti
featur
also
concert
key
chemic
featur
hba
hyar
pharmacophor
model
success
employ
structur
queri
virtual
screen
databas
identif
new
potent
chymas
inhibitor
thu
electrostat
potenti
inhibitor
play
signific
role
bind
interact
chymas
togeth
orbit
energi
consequ
influenc
inhibit
effect
set
structur
distinct
compound
report
chymas
inhibitor
divers
experiment
known
inhibitori
activ
ic
data
compil
literatur
life
scienc
journal
inhibitori
activ
obtain
use
biolog
assay
method
form
train
set
compound
distinct
structur
motif
wide
activ
rang
nm
select
compound
train
set
energi
minim
process
perform
charmm
forcefield
pole
algorithm
appli
gener
maximum
divers
conform
energi
threshold
calcul
energi
minimum
everi
compound
dataset
conform
gener
use
divers
conform
gener
protocol
run
bestflex
conform
gener
option
avail
accelri
discoveri
studio
ds
accelri
san
diego
ca
usa
method
ensur
best
coverag
conform
space
perform
rigor
energi
minim
torsion
cartesian
space
use
pole
algorithm
train
set
compound
associ
conform
submit
hypogen
modul
ds
hypogen
algorithm
implement
pharmacophor
hypothesi
gener
process
execut
three
phase
name
construct
subtract
optim
phase
construct
phase
identif
featur
common
activ
compound
take
place
wherea
pharmacophor
featur
also
present
least
activ
compound
remov
subtract
phase
final
optim
phase
hypothesi
score
improv
regress
paramet
use
estim
activ
valu
train
set
compound
relationship
geometr
fit
valu
activ
valu
util
comput
pharmacophor
hypothes
show
best
correl
arrang
featur
given
train
set
compound
correspond
pharmacolog
activ
form
rank
sever
structur
activ
relationship
sar
pharmacophor
model
deriv
train
set
compound
use
hypogen
modul
ds
studi
top
hypothes
return
hypothes
gener
process
signific
statist
paramet
select
calcul
gener
quantit
pharmacophor
model
valid
find
whether
compet
enough
identifi
activ
structur
estim
activ
valu
precis
valid
process
perform
base
test
set
predict
fischer
random
method
develop
statist
model
follow
three
crossvalid
method
often
use
examin
model
predictor
effect
practic
applic
independ
dataset
test
subsampl
test
jackknif
test
howev
three
test
method
jackknif
test
deem
object
reason
follow
independ
dataset
test
although
sampl
use
test
model
predictor
outsid
train
dataset
use
train
exclud
memori
effect
bia
way
select
independ
sampl
test
model
predictor
could
quit
arbitrari
unless
number
independ
protein
suffici
larg
kind
arbitrari
might
result
complet
differ
conclus
instanc
model
predictor
achiev
higher
success
rate
model
predictor
given
independ
test
dataset
might
fail
keep
test
anoth
independ
test
dataset
ii
subsampl
test
concret
procedur
usual
use
literatur
crossvalid
problem
kind
subsampl
test
number
possibl
select
divid
benchmark
dataset
astronom
figur
even
simpl
dataset
elucid
demonstr
equat
therefor
actual
subsampl
crossvalid
test
extrem
small
fraction
possibl
select
taken
account
sinc
differ
select
alway
lead
differ
result
even
benchmark
dataset
model
predictor
subsampl
test
avoid
arbitrari
either
test
method
unabl
yield
uniqu
outcom
deem
good
one
iii
jackknif
test
sampl
benchmark
dataset
singl
onebyon
test
model
predictor
train
remain
sampl
process
jackknif
train
dataset
test
dataset
actual
open
sampl
turn
move
two
jackknif
test
exclud
memori
effect
also
arbitrari
problem
mention
independ
dataset
test
subsampl
test
avoid
outcom
obtain
jackknif
crossvalid
alway
uniqu
given
benchmark
dataset
accordingli
jackknif
test
increasingli
wide
use
investig
strong
math
background
examin
qualiti
variou
predictor
see
eg
howev
reduc
comput
time
adopt
independ
test
dataset
crossvalid
studi
done
mani
investig
svm
predict
engin
test
set
compris
compound
experiment
known
chymas
inhibitori
activ
valu
use
test
set
predict
method
ligand
pharmacophor
map
protocol
run
bestflex
conform
gener
option
use
map
test
set
compound
fischer
random
method
avail
ds
appli
train
set
compound
prove
gener
pharmacophor
model
obtain
chanc
pharmacophor
use
predict
model
find
novel
potenti
lead
suitabl
develop
abl
detect
compound
known
inhibitori
activ
order
identifi
new
potenti
lead
compound
select
pharmacophor
model
subsequ
use
structur
search
queri
screen
maybridg
chembridg
chemic
databas
consist
structur
assort
compound
respect
queri
perform
use
ligand
pharmacophor
map
protocol
run
bestflex
search
method
ds
retriev
hit
molecul
must
fit
featur
pharmacophor
hypothesi
hit
obtain
databas
screen
filter
use
lipinsiki
rule
five
order
carri
druglik
compound
studi
comput
dock
oper
use
vehicl
investig
interact
protein
receptor
ligand
reveal
bind
mechan
demonstr
seri
studi
dock
play
signific
role
predict
bind
orient
affin
small
molecul
drug
candid
protein
target
known
structur
henc
dock
serv
import
tool
ration
computerassist
drug
design
gold
genet
optim
ligand
dock
cambridg
crystallograph
data
center
uk
use
genet
algorithm
dock
ligand
protein
bind
site
explor
full
rang
ligand
conform
flexibl
partial
flexibl
protein
studi
util
dock
train
set
compound
along
new
hit
retriev
chemic
databas
protein
coordin
crystal
structur
chymas
cocrystal
pdb
id
determin
resolut
use
defin
activ
site
water
molecul
present
protein
remov
hydrogen
atom
ad
activ
site
defin
radiu
around
ligand
present
crystal
structur
end
comput
topscor
conform
everi
ligand
save
earli
termin
option
appli
pass
genet
optim
calcul
five
conform
particular
compound
envisag
within
rm
deviat
valu
gold
fit
score
calcul
contribut
hydrogen
bond
van
der
waal
interact
protein
ligand
intramolecular
hydrogen
bond
strain
ligand
proteinligand
interact
scrutin
ds
far
comput
techniqu
consid
mani
practic
ascertain
dft
take
account
exchang
correl
effect
effect
like
one
best
method
studi
mediums
larger
molecular
system
appropri
qsar
studi
exhibit
excel
perform
semiempir
method
ab
initio
method
complet
geometri
optim
data
set
compound
carri
use
dft
beck
threeparamet
exchang
potenti
leeyangparr
correl
function
use
basi
set
level
use
kind
net
atom
charg
call
electrostat
potenti
esp
fit
charg
deriv
dft
calcul
molecular
electrostat
potenti
distribut
use
chelpg
method
produc
charg
fit
electrostat
potenti
point
select
vibrat
frequenc
comput
level
character
stationari
point
correspond
potenti
energi
surfac
calcul
perform
use
gaussian
suit
program
base
structur
divers
wide
biolog
activ
rang
four
chymas
inhibitor
includ
least
activ
compound
select
train
set
three
final
hit
retriev
maybridg
databas
select
pharmacophor
model
show
import
result
respect
properti
like
molecular
interact
activ
site
compon
estim
activ
calcul
druglik
properti
high
gold
fit
score
also
select
thu
data
set
employ
dft
studi
consist
seven
compound
variou
quantumchem
descriptor
lumo
homo
locat
molecular
electrostat
potenti
mesp
comput
map
electrostat
potenti
establish
techniqu
investig
biolog
activ
compound
play
key
role
initi
step
ligandreceptor
interact
format
checkpoint
file
compound
gener
geometr
optim
comput
use
input
cubegen
program
interfac
gaussian
program
comput
mesp
mesp
isopotenti
surfac
produc
superimpos
onto
total
electron
densiti
surfac
eau
electrostat
potenti
whole
molecul
final
obtain
superimpos
electrostat
potenti
upon
total
electron
densiti
surfac
compound
sinc
userfriendli
publicli
access
webserv
repres
futur
direct
develop
practic
use
model
predictor
shall
make
effort
futur
work
provid
webserv
method
present
studi
combin
variou
theoret
method
like
pharmacophor
model
databas
screen
molecular
dock
dft
calcul
investig
identif
novel
chymas
inhibitor
specifi
key
factor
crucial
bind
interact
chymas
inhibitor
perform
highli
correl
r
pharmacophor
model
two
hydrogen
bond
acceptor
three
hydrophob
aromat
featur
gener
success
valid
use
test
set
fischer
random
method
use
databas
screen
hit
compound
subject
variou
druglik
filtrat
molecular
dock
studi
final
three
structur
divers
compound
high
estim
activ
strong
molecular
interact
key
activ
site
amino
acid
identifi
furthermor
dft
studi
articul
influenc
electrostat
featur
compound
inhibitori
activ
well
perform
analysi
orbit
energi
plot
mesp
shown
clear
trend
electron
properti
inhibitori
activ
ic
data
increas
trend
observ
ic
homo
energi
valu
molecular
electrostat
potenti
featur
also
consist
key
chemic
featur
thu
success
valid
dft
method
therefor
result
studi
help
develop
new
potent
hit
chymas
also
provid
better
understand
interact
chymas
inhibitor
turn
assist
ration
design
novel
potent
enzym
inhibitor
